A COVID-19 hospitalized patient registry is being considered nationwide to gather real-time knowledge that will help improve remedy outcomes, analyze trends in pandemic progression, and calibrate the response, authorities said.
ICMR, in collaboration with the Ministry of Health and AIIMS, plans to identify the national clinical registry that will help researchers and policy makers perceive the effectiveness of experimental therapies, ongoing adverse occasions and generate evidence to improve the remedy of COVID-19 patients.
“The purpose is to gather knowledge about patients hospitalized by COVID-19, such as clinical and laboratory characteristics, demographics, comorities, results of remedies, headaches, in all age groups, among others,” officials said.
The new coronavirus, SARS-CoV-2 and the disease it causes have so many unknown parameters that clog and control the disease, they said.
“A comprehensive and systematic database covering other regions of the country will enable researchers and policymakers to generate applicable assumptions, inform COVID 19 critics, find trends in pandemic progression, and calibrate the pandemic reaction accordingly,” said one official.
Fifteen nationally recognized institutions, adding the Postgraduate Institute of Education and Medical Research (PGIMER) in Chandigarh, AIIMS Delhi, AIIMS Jodhpur, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru and Armed Force Medical College in Pune will join hospitals and physician to address them.
These 15 establishments would be the sites of the registry and would oversee about a hundred COVID-19 hospitals that would be called satellite centres from which knowledge would be collected, as a component of the exercise.
The proposal was sent for approval to the ICMR Central Committee for the Ethics of Human Research (CECHR).
“Knowledge will help improve clinical control protocols because the repository would help us know which drug works most productively in which age group, the effectiveness of experimental treatments and the side effects that occur. The concept is to produce evidence to improve the COVID remedy -19 patients,” said some other official.
Get live equity costs from BSE, NSE, U.S. market. And the latest liquidity value, mutual fund portfolio, calculate your taxes, the source of the income tax calculator, meet the most productive winners on the market, the most productive losers and the most productive equity funds. Like it on Facebook and stay with us on Twitter.
Financial Express is now on Telegram. Click here to register on our channel and stay up to date with the latest News and Updates from Biz.